title: The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness.
authors.forename: Serdar M
authors.initials: SM
authors.lastname: Dursun
authors.forename: Hiram Joseph
authors.initials: HJ
authors.lastname: Wildgust
authors.forename: Paul
authors.initials: P
authors.lastname: Strickland
authors.forename: Guy M
authors.initials: GM
authors.lastname: Goodwin
authors.forename: Leslie
authors.initials: L
authors.lastname: Citrome
authors.forename: Mike
authors.initials: M
authors.lastname: Lean
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000150:complications; D001523:Mental Disorders / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents